sGCα1 mediates the negative inotropic effects of NO in cardiac myocytes independent of changes in calcium handling
Authors:
- Sharon M. CawleySharon M. Cawley
- Alessio AlognaAAAlessio Alogna
- Michael SchwarzlMSMichael Schwarzl
- Martin ManningerMMMartin Manninger
- Nazha HamdaniNHNazha Hamdani
- Birgit ZirngastBZBirgit Zirngast
- Benjamin KlothBKBenjamin Kloth
- 1 July 2011
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 301 (1) , H157-H163
Abstract
In the heart, nitric oxide (NO) modulates contractile function; however, the mechanisms responsible for this effect are incompletely understood. NO can elicit effects via a variety of mechanisms including S-nitrosylation and stimulation of cGMP synthesis by soluble guanylate cyclase (sGC). sGC is a heterodimer comprised of a β1- and an α1- or α2-subunit. sGCα1β1 is the predominant isoform in the heart. To characterize the role of sGC in the regulation of cardiac contractile function by NO, we compared left ventricular cardiac myocytes (CM) isolated from adult mice deficient in the sGC α1-subunit (sGCα1−/−) and from wild-type (WT) mice. Sarcomere shortening under basal conditions was less in sGCα1−/− CM than in WT CM. To activate endogenous NO synthesis from NO synthase 3, CM were incubated with the β3-adrenergic receptor (β3-AR) agonist BRL 37344. BRL 37344 decreased cardiac contractility in WT CM but not in sGCα1−/− myocytes. Administration of spermine NONOate, an NO donor compound, did not affect sarcomeric shortening in CM of either genotype; however, in the presence of isoproterenol, addition of spermine NONOate reduced sarcomere shortening in WT but not in sGCα1−/− CM. Neither BRL 37344 nor spermine NONOate altered calcium handling in CM of either genotype. These findings suggest that sGCα1 exerts a positive inotropic effect under basal conditions, as well as mediates the negative inotropic effect of β3-AR signaling. Additionally, our work demonstrates that sGCα1β1 is required for NO to depress β1/β2-AR-stimulated cardiac contractility and that this modulation is independent of changes in calcium handling.Keywords
This publication has 51 references indexed in Scilit:
- cGMP Signals Modulate cAMP Levels in a Compartment-Specific Manner to Regulate Catecholamine-Dependent Signaling in Cardiac MyocytesCirculation Research, 2011
- PDE5 Inhibition With Sildenafil Improves Left Ventricular Diastolic Function, Cardiac Geometry, and Clinical Status in Patients With Stable Systolic Heart FailureCirculation: Heart Failure, 2011
- PDE5A suppression of acute β-adrenergic activation requires modulation of myocyte beta-3 signaling coupled to PKG-mediated troponin I phosphorylationBasic Research in Cardiology, 2010
- Phosphodiesterase 5 restricts NOS3/Soluble guanylate cyclase signaling to L-type Ca2+ current in cardiac myocytesJournal of Molecular and Cellular Cardiology, 2009
- Deficient ryanodine receptor S -nitrosylation increases sarcoplasmic reticulum calcium leak and arrhythmogenesis in cardiomyocytesProceedings of the National Academy of Sciences, 2007
- Modulation of In Vivo Cardiac Function by Myocyte-Specific Nitric Oxide Synthase-3Circulation Research, 2004
- Inhibition of cyclic GMP hydrolysis with zaprinast reduces basal and cyclic AMP‐elevated L‐type calcium current in guinea‐pig ventricular myocytesBritish Journal of Pharmacology, 2003
- Effects of nitric oxide donors on cardiac contractility in wild-type and myoglobin-deficient miceBritish Journal of Pharmacology, 2002
- cGMP-Dependent Protein Kinase I Mediates the Negative Inotropic Effect of cGMP in the Murine MyocardiumCirculation Research, 2002
- Tissue Distribution of the Human Soluble Guanylate CyclasesBiochemical and Biophysical Research Communications, 1999